Long-term complete responses after (131)I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma

por Buchegger, F, Antonescu, C, Delaloye, A Bischof, Helg, C, Kovacsovics, T, Kosinski, M, Mach, J-P, Ketterer, N
Publicado 2006

Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony...

por Leyvraz, S., Ketterer, N., Perey, L., Bauer, J., Vuichard, P., Grob, J. P., Schneider, P., von Fliedner, V., Lejeune, F., Bachmann, F.
Publicado 1995